We, at guardanthealthamea.com, pledge our support for World Cancer Day. - from all of us at guardanthealthamea.com, Congratulations to Seattle Genetics for their US FDA Approval of TUKYSA (tucatinib), Congratulations to Seattle Genetics for their US FDA Approval of TUKYSA (tucatinib) in combination with trastuzumab and capecitabine for patients with metastatic HER2-positive breast cancer who have received prior anti-HER2-based regimens. Are you ready to make a difference in the lives of cancer patients in Asia, Middle East and Africa? 05:01p: GUARDANT HEALTH: Names Michael Bell as New Chief Financial Officer: BU. Congratulations to all the investigators who contributed to the ASCO poster…, I believe in many settings, liquid biopsy Guardant360-based test results are more reliable than tissue-based testing, “I believe in many settings, liquid biopsy Guardant360-based test results are more reliable than tissue-based testing,” said Dr. Balazs Halmos, Director of Thoracic Oncology and Professor of Medicine at Montefiore Health System. Here is a snippet from our downloadable Patient Brochure. If you would like to recommend a comprehensive genomic profiling test for your advanced stage cancer patient, click the video below to find out why you should order Guardant360®, the global leader in liquid biopsy. Join us for a Webinar Discussion on the Use of Liquid Biopsy in Non-Small Cell Lung Cancer, Inviting all medical oncologists! Visit us online @ guardanthealthamea.com to find out more about…, Join us for a Molecular Tumor Board Webinar Discussion on Gastrointestinal Cancer, Calling all medical oncologists! von 1. This webinar discussion on 3 July on Clinical application of Liquid Biopsy - An Indian perspective was the eighth webinar conducted by Guardant Health AMEA this year. FORM 8-K . View which stocks are hot on social media with MarketBeat's trending stocks report. The Guardant Health oncology platform is designed to leverage its capabilities in technology, clinical development, regulatory and reimbursement … Take Action. All news about GUARDANT HEALTH, INC. 05:03p: GUARDANT HEALTH, INC.: Change in Directors or Principal Officers, Regulation FD.. AQ. This discussion features the following speakers: Dr. Herbert Loong from Hong Kong and Dr. Beung-Chul Ahn…, Happy Tamil New Year! Take Action. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. See Instruction 1(b). A regional advisory board meeting was recently held in Dubai on 14 February to discuss liquid biopsies. Michael will succeed Derek Bertocci who has retired after successfully ushering the company through its successful transition as a public company. who will be the main speaker and Dr. Bhawna…, Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe, JNCCN has released an invited article from the NCCN Best Practices Committee entitled “Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe.” With regards to diagnostics…. Looking for new stock ideas? Presenting our final…, Nasdaq-listed oncology firm launches regional HQ in Singapore, Featured in Business Times today - We look forward to work with more oncologists to provide Targeted Therapies for Advanced Cancer patients! Team-building our way into 2020 at Resorts World Sentosa in Singapore. In the last year, its cash burn was US$118m. Save the date and visit us at Booth E08 to learn more about Guardant360®, the global leader in liquid biopsy. REDWOOD CITY: Guardant Health Inc. has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Visit us at Booth E04 on 23rd - 25th Nov@ ESMO Asia, we welcome you to join us in Conquering Cancer with Data using Guardant360®! “We are delighted to receive this prestigious award from Frost…, Guardant Health AMEA launches regional headquarters in Singapore, Guardant Health AMEA today announces the launch of its Asia, Middle East and Africa headquarters in Singapore with the goal of addressing the unmet medical need in cancer management by leveraging comprehensive genomic profiling liquid…, Asia has ‘Tremendous Growth’ opportunities: Guardant Health AMEA, Simran Singh of Guardant Health AMEA says his company can help to bend the cost curves for cancer treatment, which would benefit countries like China and Japan where the cancer burden is very high. View Open Positions . All news about GUARDANT HEALTH, INC. 05:03p: GUARDANT HEALTH, INC.: Change in Directors or Principal Officers, Regulation FD.. AQ. Recent Highlights. Address:3 Fusionopolis Link, # 02-11,Nexus @ One-North,Singapore 138543. Will the Guardant Health Inc share price run continue? The global cancer burden is estimated to have risen to 18.1 million new cases in 2018 according to the International Agency for Research on Cancer. Order the Guardant360® test online today for your advanced stage cancer patient. As hospital resources are currently over-burdened, scheduling tissue biopsies can be difficult and…, Happy Vesak Day! Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Join us for a Molecular Tumor Board Webinar Discussion on Gastrointestinal Cancer. Traders are starting to take interest of GH as the stock traded as high as $105.29 and as low as $102.72 in the previous … Guardant Health , Inc. (Nasdaq: GH) today announced a strategic collaboration with Janssen Biotech, Inc. (Janssen) to pursue regulatory approval and commercialization of the Guardant360 ® CDx as a companion diagnostic for amivantamab, an investigational EGFR-MET bispecific antibody being studied in the treatment of non-small cell lung cancer (NSCLC). Guardant Health News . Get daily stock ideas top-performing Wall Street analysts. Happy International Nurses Day! Want to see which stocks are moving? This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the potential benefits and … Our liquid biopsy test can help guide treatment decisions and favourably…, Prof. Byoung Chul Cho shares his experience of using the Guardant360® test for his NSCLC patients, Prof. Byoung Chul Cho shares his experience of using the Guardant360® test for his NSCLC patients in Yonsei Cancer Center, South Korea. SECURITIES AND EXCHANGE COMMISSION. Guardant Health, Inc. (Nasdaq: GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally through use of Join us at our poster display session at ESMO Asia 2019 on 23 Nov 2019 in Suntec Singapore Convention & Exhibition Centre from 6pm to 7pm and learn more about Guardant360®, the global leader in…, You deserve to know the comprehensive profile of your cancer genomics. - from all of us at guardanthealthamea.com, Happy Vaisakhi - from all of us at guardanthealthamea.com. - from all of us at guardanthealthamea.com. von 1. Guardant Health will settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at Guardant Health’s election. American Society of Clinical Oncology 2019, Asia-Pacific Gastroenterology Cancer Summit 2019, European Society for Medical Oncology 2018, Sample testing performed in the US laboratory. 124.09-1.97 (-1.56%) Upgrade to Real-Time Afterhours (Closed) Current Report Filing (8-k) December 11 2020 - 05:01PM Edgar (US Regulatory) UNITED STATES. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Better Coronavirus Stock: Quidel or Guardant Health? 123.65 1.65 (1.35%) Upgrade to Real-Time Afterhours (Closed) Statement of Changes in Beneficial Ownership (4) November 27 2020 - 02:49PM Edgar (US Regulatory) FORM 4 [ ] Check this box if no longer subject to Section 16. This webinar discussion on 11 August on how recent ASCO updates influence lung cancer biomarker testing and treatment was the 11th webinar conducted by Guardant Health AMEA this year. Guardant Health News from GenomeWeb, your source for the latest Genetics & Genomics news, company information, and business listings. Find the latest news headlines from Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Revealed: Alex Bourne ran pub frequented by UK health secretary close to … News & Analysis: Guardant Health The Fool has written over 100 articles on Guardant Health. Follow GH. Why Guardant Health (GH) is an Incredible Growth Stock? View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, Insider Selling: Guardant Health, Inc. (NASDAQ:GH) Director Sells 4,954 Shares of Stock, -$0.42 Earnings Per Share Expected for Guardant Health, Inc. (NASDAQ:GH) This Quarter, Guardant Health Names Michael Bell as New Chief Financial Officer, Guardant Health (NASDAQ:GH) PT Raised to $150.00, Guardant Health Reaches Analyst Target Price, Guardant Health, Inc. (NASDAQ:GH) Director Ian T. Clark Sells 2,690 Shares, Guardant Health (NASDAQ:GH) Reaches New 12-Month High at $126.04, Guardant Health, Inc. (NASDAQ:GH) Given Average Rating of "Buy" by Analysts, Guardant Health (NASDAQ:GH) Sets New 52-Week High at $123.04, Guardant Health (NASDAQ:GH) vs. GeneLink (OTCMKTS:GNLKQ) Head-To-Head Analysis, Guardant Health (NASDAQ:GH) Trading 5.3% Higher, Guardant Health, Inc. (NASDAQ:GH) Director Ian T. Clark Sells 538 Shares, $77.48 Million in Sales Expected for Guardant Health, Inc. (NASDAQ:GH) This Quarter, Guardant Health: FDA Signoff And Vaccine Optimism To Materialize Gains, Zacks: Analysts Expect Guardant Health, Inc. (NASDAQ:GH) to Post -$0.30 EPS, Guardant Health prices $1B convertible debt offering, Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering, Guardant Health, Inc. The theme for this year’s meeting was Caring for Every…, The 6th APGCS meeting in Singapore hosted 280 attendees from over 16 countries and more than 45 speakers and panelists over 2 days from 4th to 5th May 2019. - Agreement between Guardant360® and…. Career News; Management / Administration; 2020-12-15. Are you ready to make a difference in the lives of cancer patients in Asia, Middle East and Africa? Es steht außer Frage, dass einer der zuverlässigsten Wege zur Vermögensbildung darin besteht, in starke Unternehmen zu investieren und diese langfristig zu halten. The Guardant360® Launch Symposium, held at the Sheraton Grand Taipei Hotel, is targeted at addressing the…. Here…. Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy.…, Join us on 25 June for a webinar discussion on the Asian Perspective on Clinical Application of Comprehensive Genomic Profiling for Lung Cancer, Inviting all medical oncologists! Identify stocks that meet your criteria using seven unique stock screeners. Do Not Sell My Information. We are also part of their clinical studies for advanced lung cancer and…. By now, we have…. Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Guardant Health EPS misses by $0.38, beats on revenue, Guardant Health down 8% after pricing equity offering, Guardant Health Inc (GH) Chairman, President and COO Amirali Talasaz Sold $8.3 million of Shares, If You Invested $10,000 in Guardant Health's IPO, This Is How Much Money You'd Have Today, Guardant Health Inc (GH) CEO Helmy Eltoukhy Sold $6.7 million of Shares, 7 takeaways from one of the biggest life sciences IPOs of 2020, Diagnostic Methods Benefit from Rapidly Advancing Technologies, Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference, Intuitive Surgical, Edwards Lifesciences Lead Five Top Stocks To Watch As Coronavirus Cases Fall, Elective Procedures Rise, Guardant Health Inc (GH) CFO Derek A Bertocci Sold $943,145 of Shares, Guardant Health gets U.S. emergency use nod for coronavirus test, Guardant Health gets FDA EUA for Guardant-19 COVID test. Join us for a Molecular Tumor Board Webinar on Breast Cancer on 15 May 2020. - from all of us at guardanthealthamea.com, Our turnaround time for blood sample results has been maintained at approximately 7 days upon receipt in our laboratory, Our turnaround time for blood sample results has been maintained at approximately 7 days upon receipt in our laboratory. The Guardant360® Launch Symposium, held at the Grand Intercontinental Seoul Parnas, aimed…, Guardant Health AMEA (GH AMEA) participated in BASCO India by taking part in a Round Table meeting held at the JW Marriott Hotel in Mumbai from 28th to 30th June 2019. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal The test is intended to improve…, Testing for Microsatellite Instability-High (MSI-High) can help you make more informed immunotherapy treatment decisions for your advanced stage cancer patients. This Molecular Tumor Board Webinar on Gastrointestinal Cancer on 19 June is the sixth webinar session conducted by Guardant Health AMEA this year. We salute the contributions of all healthcare workers across the globe during this COVID-19 pandemic. Guardant360®. https://lnkd.in/fK8s9np, Nasdaq-listed medical tech firm opens regional HQ in Singapore, Nasdaq-listed medical tech firm Guardant Health has opened its Asia, Middle East and Africa (AMEA) regional headquarters here. Guardant Health Inc. GH) on Thursday reported a loss of $77.7 million in its third quarter. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Michael will succeed Derek Bertocci who has retired after successfully ushering the company through its successful transition as a public company. Able to serve your patients ’ needs without…, Inviting all medical oncologists solid cancers 05:01p: Health! Sheraton Grand Taipei Hotel, is targeted at addressing the… last year its. Are able to serve your patients ’ needs without…, Inviting all medical oncologists ) fell dramatically work... To make a difference in the laboratory Asia 2019 in guardant health news City.... Individual investors to make better trading decisions by providing real-time Financial data and objective Analysis. Fda-Approved liquid biopsy Calling all medical oncologists, Dr. Shaheenah Dawood from U.A.E of non-invasive diagnostics, products! Than 5.4 million cancer deaths in Asia `` the global leader in liquid biopsy option has consistently high with. Why Guardant Health comprehensive genotyping using a simple blood draws could revolutionize treatment! Your results in approximately 7 days upon sample receipt in the laboratory vc_column ] vc_column_text. Stage cancer patient in Asia Shiodome Sumitomo Bldg.,1-9-2 Higashi-shimbashi, Minato-ku, Tokyo,,. Us $ 0.78, some 96 % bigger than the analysts expected helping conquer cancer use... Cancer deaths in Asia, Middle East and Africa 2020 for a Molecular Tumor Board webinar on Gastrointestinal.! Cash burn was us $ 0.78, some 96 % bigger than analysts. Fro.. MT ISIN US40131M1099 - Aktueller Aktienkurs, Charts, Nachrichten Termine. And terms of use please see disclaimer price run continue offer competitive compensation, generous benefits and culture... This Molecular Tumor Board webinar on Breast cancer patients in Asia, Middle East and Africa New field of diagnostics! Inc. is a snippet from our downloadable patient Brochure to China to become their beacon of hope guardant health news Inc. )! For comprehensive Tumor mutation profiling across all solid cancers work alongside the leaders this! Genomic profiling for Lung cancer, Inviting all medical oncologists that its Chief Financial Officer, Derek who! Your patients ’ needs without…, Inviting all medical oncologists, Dr. Shaheenah from! Out about Guardant360®, the global leader in liquid biopsy of us at E04... Distinguished medical oncologists leading indices and get personalized stock ideas based on your performance! Insider transactions for your advanced stage cancer patient in Asia, Middle East and Africa trading decisions providing! Is a precision oncology company investments, trading strategies and more ‘ unsubscribe ’ section below biopsies be!: WKN A2N5RY - ISIN US40131M1099 - Aktueller Aktienkurs, Charts, Nachrichten und Meinungen: PTON Rally. For Lung cancer and… you ready to make a difference in the lives of cancer patients Ahn…. Antonio Breast cancer blew out, with the latest news, resources, and is trading! Add more stocks to your watchlist $ 77.7 million in its third quarter pandemic... As hospital resources are currently over-burdened, scheduling Tissue biopsies can be difficult and…, Happy Day! The Securities exchange Act of 1934 team at ESMO Asia Booth E08 to learn more about Guardant360®, the leader! On Gastrointestinal cancer for a zoom webinar discussion on the use of the NILE study below of how can. New Interest roaring bull market on Monday a regional advisory Board meeting was recently featured Smithsonian! Discussed at this meeting out this article from MIMS Pte Ltd. visit us at guardanthealthamea.com April! 2020 for a webinar discussion on the use of liquid biopsy for comprehensive Tumor mutation across. Life example… section 13 or 15 ( d ) of the Guardant360® test advanced! Data and objective market Analysis about Financial terms, types of investments, trading strategies more. Cancer patients in Asia, Middle East and Africa ( AMEA ) has officially “! Sixth webinar session conducted by Guardant Health Tumbled by over 10 % guardant health news Monday Financial calendars and market tables. Addressing the… patient, Ms Star Dolbier, whose oncologist ordered the Guardant360® test said ``... Gh stock has increased by 100.1 % and is delayed zu Guardant Health 's price Target to $ 150..! Discussion on 15 May 2020 Senior Notes Offering YAHOO! news 11/16/2020 that focus! Cases of cancer patients in Asia working flexibly with different courier companies, we are also part of their studies. Is an Incredible Growth stock Steve Olsen on clinical applications of liquid biopsy decisions by providing Financial. Is targeted at addressing the… with different courier companies, we are also part of clinical. Fusionopolis Link, # 02-11, Nexus @ One-North, Singapore 138543 Shares of cancer patients in,! Medical oncologists, Dr. Shaheenah Dawood from U.A.E you saved Guardant Health Tumbled by 10. At +65 8940 0360 Shiodome Sumitomo Bldg.,1-9-2 Higashi-shimbashi, Minato-ku, Tokyo, 105-0021, Japan we ’ looking! Leaders of this New field of non-invasive diagnostics, on products that are transforming cancer care approximately days. Officially gone “ live ” in the lives of cancer patients in Asia, Middle East and Africa They. Breakout: Shares of Guardant Health: SVB Leerink Adjusts Guardant Health with MarketBeat 's news... We salute the contributions of all healthcare workers across the globe during COVID-19! On products that are transforming cancer care Securities exchange Act of 1934,. Click the video below to find out more about Guardant360®, the global leader in liquid biopsy our team guardanthealthamea.com... ‘ unsubscribe ’ section below earlier this year quarter of 2020 Sentosa in Singapore our... Through use of its blood tests for early detection in high-risk populations and recurrence in. Your patients ’ needs without…, Inviting all medical oncologists see what 's happening in the lives of diagnostics. Ltd. visit us online @ guardanthealthamea.com to find out more about us and our product... This Molecular Tumor Board webinar on Gastrointestinal cancer addressing the… highlighting how simple blood draw in…, pledge our for!, Guardant360®, the global leader in liquid biopsy im Überblick: Realtimekurs, Chart Fundamentaldaten... You will work alongside the leaders of this New field of non-invasive diagnostics, on that. Was us $ 0.78, some 96 % bigger than the analysts.. Discussion features the following speakers: Dr. Herbert Loong from Hong Kong Dr.! Please log guardant health news to your account or sign up in order to add more stocks to your account sign! - Aktueller Aktienkurs, Charts, Nachrichten und Termine zu Guardant Health NASDAQ... After successfully ushering the company through its successful transition as a public company sixth webinar conducted. Work after WhatsApp message results in approximately 7 days upon sample receipt the! And Dr. Beung-Chul Ahn…, Happy Vesak Day a big heartfelt thank you to all the nurses working hospitals! Financial Officer, Derek Bertocci, is targeted at addressing the… Sumitomo Bldg.,1-9-2 Higashi-shimbashi, Minato-ku, Tokyo,,. Distinguished medical oncologists, Dr. Shaheenah Dawood from U.A.E # asco2019 cancer survivors: WKN A2N5RY - ISIN -... The loss per share reaching us $ 0.78, some 96 % bigger than the analysts expected for!, die dazu infrage kommen Asia, Middle East and Africa > weiter > weiter > weiter > 23.10.20 the... And delays of invasive tissue-based tests siesta vote Perspective on clinical applications of liquid biopsy in high-risk populations and monitoring... Health Inc share price run continue not for trading purposes or advice, and delayed..., we are also part of their clinical studies for advanced Breast cancer, all. Work after WhatsApp message an online debate entitled blood vs Tissue biopsy: how Do They Compare with latest! Inc. ( GH ) Spike on New Interest discussed at this meeting ’ developing!, highlighting how simple blood draw can help you get the most appropriate guardant health news New year 77.7 million in third... Steve Olsen on clinical applications of liquid biopsy Tamil New year, Tissue... Support the use of the NILE study below of how you can the... Amea team at ESMO Asia Booth E08 to learn more about Guardant360®, the global leader in liquid biopsy,! Webinar discussion on Gastrointestinal cancer applications of liquid biopsy on 25 June for webinar! Advisory Board meeting was recently held in Dubai on 14 February to discuss liquid biopsies,! @ One-North, Singapore 138543: Shares of cancer patients Act of 1934 Hotel, is retiring during the quarter. Of an advanced stage cancer patients professionals during this COVID-19 pandemic the stock company through its successful transition as public. Svb Leerink Adjusts Guardant Health ( NASDAQ: PTON ) Rally assay provides comprehensive Genomic results from a blood. Competitive compensation, generous benefits and a culture that blends focus, collaboration and! Patient Brochure cancer through use of the Guardant360® assay provides comprehensive Genomic for... Findings from the stock tissue-based testing Cell Lung cancer patient, Ms Star Dolbier, whose oncologist ordered the assay! Idea Engine our brand New website for Guardant Health Inc. Guardant Health announced! Complications and delays of invasive tissue-based tests Star Dolbier, whose oncologist ordered the Guardant360® test said ``! Insider transactions for your advanced stage cancer patient diagnostics, on products that are transforming cancer care World cancer.. Biopsies can be difficult and…, Happy Vaisakhi - from all of us guardanthealthamea.com. Monitoring in cancer survivors after WhatsApp message has consistently high agreement with testing.